insights_auto
Outlook: 57.1% bullish·0.0% bearish
Go to analysischevron_right
ORKA:NASDAQ
Oruka Therapeutics Inc
$96.87
arrow_upward
+0.23%(+0.22) 1D
$96.50
arrow_downward
-0.38% (-0.37)bedtimeAfter hours
Closed: Oct 30, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 12 analysts giving stock ratings to ORKA in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ORKA in the last 3 months.
Highest
Current $96.87
$200.00 (+106.46%)
Average
$151.90 (+56.81%)
Lowest
$105.00 (+8.39%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
David Risinger Leerink Partners | Buy | Reiterated | - | - | 10/27/2026 |
Unknown Analyst Wedbush | Buy | Reiterated | $165.00 | +70.3% | 10/27/2026 |
Mitchell Kapoor H.C. Wainwright | Buy | Reiterated | $120.00 | +23.9% | 10/27/2026 |
Etzer Darout Barclays | Buy | Maintained | $160.00 | +65.2% | 10/27/2026 |
Julian Harrison BTIG | Buy | Reiterated | $151.00 | +55.9% | 10/26/2026 |
Kaveri Pohlman Clear Street | Buy | Maintained | $105.00 | +8.4% | 10/26/2026 |
Yasmeen Rahimi Piper Sandler | Buy | Maintained | $180.00 | +85.8% | 10/07/2026 |
Martin Fan Wedbush | Buy | Maintained | $165.00 | +70.3% | 09/24/2026 |
David Nierengarten Wedbush | Buy | Maintained | $165.00 | +70.3% | 09/24/2026 |
Sam Slutsky LifeSci Capital | Buy | Maintained | $175.00 | +80.7% | 09/23/2026 |
Michael Yee UBS | Buy | Maintained | $130.00 | +34.2% | 09/01/2026 |
Tyler Van Buren TD Cowen | Buy | Maintained | - | - | 08/26/2026 |
Roger Song Jefferies | Buy | Maintained | $133.00 | +37.3% | 08/11/2026 |
Yatin Suneja Guggenheim | Buy | Reiterated | $200.00 | +106.5% | 08/10/2026 |
Alex Thompson CFA Stifel Nicolaus | Buy | Maintained | $150.00 | +54.8% | 06/29/2026 |